Profil
Kyler Lei is currently Chief Financial Officer at NovaBridge Biosciences since 2025.
Formerly, Mr. Lei was Deputy General Manager & Head-Capital Markets at Sino Biopharmaceutical Ltd. from 2022 to 2025, Research Analyst at Daiwa Capital Markets (Hong Kong) Ltd. from 2020 to 2021, and Analyst at Macquarie Capital Ltd. from 2018 to 2020.
Education includes an undergraduate degree from The University of Hong Kong conferred in 2019 and a graduate degree from The Hong Kong University of Science & Technology conferred in 2022.
Postes actifs de Kyler Lei
| Sociétés | Poste | Début |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Directeur Financier/CFO | 16/10/2025 |
Anciens postes connus de Kyler Lei
| Sociétés | Poste | Fin |
|---|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Corporate Officer/Principal | 01/10/2025 |
Daiwa Capital Markets (Hong Kong) Ltd.
Daiwa Capital Markets (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2021 |
Macquarie Capital Ltd.
Macquarie Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/06/2020 |
Formation de Kyler Lei
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sino Biopharmaceutical Ltd.
Sino Biopharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company, which engages in the manufacturing and selling of pharmaceutical products | Health Technology |
University of Hong Kong
University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie Capital Ltd.
Macquarie Capital Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Hong Kong University of Science & Technology
The Hong Kong University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiwa Capital Markets (Hong Kong) Ltd.
Daiwa Capital Markets (Hong Kong) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
















